Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01190904 · ClinicalTrials.gov registry record
Hormones and Sexual Function Predict Outcomes in Revascularized Men With Diabetes
A clinical trial, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- 568
- Enrollment target
NCT01190904 is a clinical trial that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 568 participants.
The verdict
NCT01190904 has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- 568 participants
- Enrollment target
Study Summary
The purpose of this study is to find out if androgen deficiency (low levels of testosterone, a male hormone produced by the sex glands) and erectile dysfunction (sexual dysfunction) will predict over time the development of a heart attack, stroke, or death in men with Diabetes Mellitus who have angiographically proven coronary artery disease (CAD) (≥50%) with or without percutaneous coronary intervention (PCI). A substudy aims to show the different factors and processes that may show a relationship between sexual function and levels of androgen in the body to heart disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 568 participants |
| Start Date | 2010-01 |
| Est. Completion | 2016-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01190904
The ClinicalTrials.gov registry entry for NCT01190904 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 568 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01190904 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01190904 about?
NCT01190904 is a clinical study titled "Hormones and Sexual Function Predict Outcomes in Revascularized Men With Diabetes". The purpose of this study is to find out if androgen deficiency (low levels of testosterone, a male hormone produced by the sex glands) and erectile dysfunction (sexual dysfunction) will predict over time the development of a heart attack, stroke, or death in men with Diabetes Mellitus who have angi...
What is the current status of trial NCT01190904?
This trial is currently completed. The enrollment target is 568 participants. The study started on 2010-01. Estimated completion is 2016-07.
Who is sponsoring clinical trial NCT01190904?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.